T2 Biosystems, Inc. Stock Split Ratio
T2 Biosystems, Inc. had Stock Split Ratio of 100.00% as of 2023-10-12, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2024-11-14
- 2023-10-12: Stockholders' Equity Note, Stock Split, Conversion Ratio 100.00%.
- 2023-09-15: Stockholders' Equity Note, Stock Split, Conversion Ratio 100.00%.
- 2022-10-12: Stockholders' Equity Note, Stock Split, Conversion Ratio 2.00%.
- 2022-09-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month 2.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month |
|---|---|---|
| 2023-10-12 | 100.00% 10-Q · filed 2024-11-14 | |
| 2023-09-15 | 100.00% 10-Q · filed 2023-11-15 | |
| 2022-10-12 | 2.00% 10-Q · filed 2023-08-08 | |
| 2022-09-30 | 2.00% 10-Q · filed 2022-11-14 | |
| 2014-07-25 | 58.80% 10-K · filed 2015-03-04 |